◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

3B Blackbio Dx Limited (3BBLACKBIO) Financial History

Name: 3B Blackbio Dx Limited (3BBLACKBIO) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-10-27

3B Blackbio Dx Limited (3BBLACKBIO) operates in the Biotechnology industry and is headquartered in Bhopal, India with about 86 employees. Its market capitalization is roughly ₹12 billion. In the fiscal year ended 2026-03-31, 3BBLACKBIO reported ₹1.4B in revenue and ₹599M in net income.

3B Blackbio Dx Limited manufactures and sells molecular diagnostic kits in India.

Interactive charts & full statements → Open the 3BBLACKBIO valuation workbench →

3BBLACKBIO Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹1.5B	₹1.4B	₹965M	₹741M	₹618M	—
Gross Profit	₹1.1B	₹1.1B	₹708M	₹523M	₹439M	—
Operating Income (EBIT)	₹469M	₹552M	₹493M	₹322M	₹286M	—
Net Income	₹555M	₹599M	₹477M	₹321M	₹259M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3BBLACKBIO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹335M	₹354M	₹504M	₹339M	₹222M
Gross Profit	₹259M	₹279M	₹365M	₹246M	₹167M
Operating Income (EBIT)	₹72M	₹46M	₹210M	₹142M	₹116M
Net Income	₹95M	₹96M	₹217M	₹147M	₹126M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3BBLACKBIO Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹34M)	(₹26M)	(₹22M)	(₹44M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3BBLACKBIO Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹3.8B	₹3.0B	₹2.5B	₹2.1B	—
Total Liabilities	₹464M	₹247M	₹226M	₹182M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3BBLACKBIO viewer.

Other Companies in Biotechnology

2162 · Keymed Biosciences Inc. — HK$20 billion
2315 · Biocytogen Pharmaceuticals (Beijing) Co., Ltd. — HK$17 billion
1877 · Shanghai Junshi Biosciences Co., Ltd. — HK$16 billion
7666 · Metis TechBio Co., Ltd. — HK$13 billion
4875 · MediciNova, Inc. — JPY 11 billion
NUVL · Nuvalent Inc — $10 billion
9606 · Duality Biotherapeutics, Inc. — HK$9 billion
2142 · HBM Holdings Limited — HK$9 billion

← 399A All “0-9” companies 3D3D →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.